SCHMID JOHN P. purchased 26.1% of their position (4.29K shares) of XERIS BIOPHARMA HOLDINGS, INC. on the open market
Open‑market purchase worth $10.1K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/12/2024ACC: 0001867096-24-000173
Director
Since Oct 2021
+4.29K
Net shares
Net buyer
$10.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
4.29K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+4.29K
Price / share
$2.37
Trade value
$10.13K
% of position
26.1%
8/9/2024
16.40K→20.68K
Total
Net shares
+4.29K
Net value
$10.13K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/9/2024 | P · Purchase | +4.29K | $2.37 | $10.13K | 26.1% | 16.40K | 20.68K |
| Total | +4.29K | $10.13K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned113.16K
Total
113.16K direct113.16K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 113.16K | Direct |
| Total | 113.16K | 113.16K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported